tiprankstipranks
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT

Sarepta Therapeutics (SRPT) Technical Analysis

2,923 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
6Neutral
1Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Sarepta Therapeutics’s (SRPT) Moving Averages Convergence Divergence (MACD) indicator is 5.83, suggesting Sarepta Therapeutics is a Buy.
Sarepta Therapeutics’s (SRPT) 20-Day exponential moving average is 147.28, while Sarepta Therapeutics’s (SRPT) share price is $152.67, making it a Buy.
Sarepta Therapeutics’s (SRPT) 50-Day exponential moving average is 138.40, while Sarepta Therapeutics’s (SRPT) share price is $152.67, making it a Buy.

Sarepta Therapeutics (SRPT) Pivot Points

Jul 21, 2024, 10:00 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
147.61
148.97
150.54
151.90
153.47
154.83
156.40
Fibonacci
148.97
150.09
150.78
151.90
153.02
153.71
154.83
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Sarepta Therapeutics (SRPT) Moving Averages

Jul 21, 2024, 10:00 PM
Period
Simple
Exponential
MA5
151.28Buy
151.99Buy
MA10
152.37Buy
151.35Buy
MA20
147.99Buy
147.28Buy
MA50
135.38Buy
138.40Buy
MA100
130.61Buy
131.37Buy
MA200
117.50Buy
121.66Buy
Sarepta Therapeutics’s (SRPT) 10-Day exponential moving average is 151.35, while Sarepta Therapeutics’s (SRPT) share price is $152.67, making it a Buy.
Sarepta Therapeutics’s (SRPT) 100-Day exponential moving average is 131.37, while Sarepta Therapeutics’s (SRPT) share price is $152.67, making it a Buy.
Sarepta Therapeutics’s (SRPT) stock price is $152.67 and Sarepta Therapeutics’s (SRPT) 50-day simple moving average is 135.38, creating a Buy signal.
Sarepta Therapeutics’s (SRPT) stock price is $152.67 and Sarepta Therapeutics’s (SRPT) 100-day simple moving average is 130.61, creating a Buy signal.
Sarepta Therapeutics’s (SRPT) stock price is $152.67 and Sarepta Therapeutics’s (SRPT) 200-day simple moving average is 117.50, creating a Buy signal.

Sarepta Therapeutics (SRPT) Technical Indicators

Jul 21, 2024, 10:00 PM
Name
Value
Implied Action
RSI (14)
61.52
Neutral
STOCH (9,6)
35.18
Neutral
STOCHRSI (14)
20.80
Neutral
MACD (12,26)
5.83
Buy
ADX (14)
30.76
Neutral
Williams %R
-72.63
Buy
CCI (14)
25.12
Neutral
ATR (14)
5.75
-
Ultimate Oscillator
47.09
Neutral
ROC
-6.82
Sell
Sarepta Therapeutics’s (SRPT) Relative Strength Index (RSI) is 61.52, creating a Neutral signal.
Sarepta Therapeutics’s (SRPT) Trend Strength Indicator (ADX) is 30.76, creating a Neutral signal.
Sarepta Therapeutics’s (SRPT) Commodity Channel Index (CCI) is 25.12, creating a Neutral signal.
Sarepta Therapeutics’s (SRPT) Price Rate of Change (ROC) is -6.82, creating a Sell signal.

FAQ

Is SRPT a Buy, Hold, or Sell?
Based on SRPT’s technical indicators, SRPT is a Strong Buy.
    What is SRPT’s RSI (14)?
    SRPT’s RSI (14) is 61.52, which suggests SRPT is a Neutral.
      What is SRPT’s MACD?
      SRPT’s MACD is 5.83, which suggests SRPT is a Buy.
        What is SRPT’s 5-day moving average?
        SRPT’s 5-day moving average is 151.28, which suggests SRPT is a Buy.
          What is SRPT’s 20-day moving average?
          SRPT 20-day moving average is 147.99, which suggests SRPT is a Buy.
            What is SRPT’s 50-day moving average?
            SRPT’s 50-day moving average is 135.38, which suggests SRPT is a Buy.
              What is SRPT’s 200-day moving average?
              SRPT’s 200-day moving average is 117.50, which suggests SRPT is a Buy.
                What is SRPT’s Williams % R (14)?
                SRPT’s Williams % R (14) is -72.63, which suggests SRPT is a Buy.
                  What is SRPT’s CCI (14)?
                  SRPT’s CCI (14) is 25.12, which suggests SRPT is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis